about
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3Systematic review: the effects of autologous stem cell therapy for patients with liver diseaseLiver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn ratGeneration of functional human hepatic endoderm from human induced pluripotent stem cellsSelective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism.Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and FibrosisCharacterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver.Activation of stem cells in hepatic diseases.Hepatic and renal differentiation from blood-borne stem cells.Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling.Adult stem cell plasticity.Bone marrow stem cells contribute to healing of the kidney.REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stemKrüppel-Like Factor 4 Overexpression Initiates a Mesenchymal-to-Epithelial Transition and Redifferentiation of Human Pancreatic Cells following Expansion in Long Term Adherent Culture.Bone marrow stem cells and liver disease.Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study.Hepatic progenitor cells of biliary origin with liver repopulation capacityCSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure.Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived HepatocytesDifferential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosisHighly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling.Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs.Experimental hepatology applied to stem cells.Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells.Hepatic fibrogenesis: from within and outwith.Notch3 drives development and progression of cholangiocarcinoma.Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages.Markedly Increased High-Mobility Group Box 1 Protein in a Patient with Small-for-Size Syndrome.Stem cells and liver repair.Practical barriers to delivering autologous bone marrow stem cell therapy as an adjunct to liver resection.Liver development, regeneration, and carcinogenesis.Prospects for stem cell transplantation in the treatment of hepatic disease.Liver fibrogenic cells.New horizons for stem cell therapy in liver disease.Differentiation of progenitors in the liver: a matter of local choiceLinks between hepatic fibrosis, ductular reaction, and progenitor cell expansion.Preparing the ground for tissue regeneration: from mechanism to therapy.Cell therapy for liver disease: From liver transplantation to cell factory.
P50
Q24624887-2F4BDCEB-6FAB-4908-A1AE-5A8048FD50AEQ27024968-536FB41B-503F-40E0-99B2-0A9936953D31Q33291307-B6663581-1985-48E0-A636-2F15E8C87934Q33563392-74D60CA7-6A69-4E6B-87FF-D89BAE0EE3BDQ33565774-0A2C59C7-2D11-4687-941C-50A465ACB521Q33806641-5097E8BB-93DA-483C-842C-F61180A13A3AQ34534282-FC89E4A3-AE98-4B7E-8123-D694B86394E9Q34554107-465FE8F2-96DB-4AF2-9C8C-C72056D356CDQ34554113-1AC31E2B-3614-4EF0-94D1-7EDF79CB9F67Q34658441-8046030C-8C96-473E-91F5-F1CDFBC4B1C6Q34663415-2B7AC54C-E5AD-4BEC-BB34-B534DAC7A113Q34736836-4DD49F57-7939-4D41-A101-78177E16DE2DQ35133240-C7071234-BE28-4741-9CA3-B30CC5A26928Q35203746-FBA3662E-A9C4-4877-9353-EEC375CC280EQ35803267-245C4067-1A40-4F7F-9D04-EAC040B4575CQ35929494-8D724BD4-A7FD-471D-AB9A-1ECE381710E5Q36000076-D31E47BF-89AE-4140-B95B-FFBA21903E9FQ36131170-56F11C33-B904-4933-BB5B-C9FDB73DBC00Q36181615-9FC2D823-5FE0-4161-A3AC-310C33F235C2Q36353138-5F132352-CE66-426A-8190-AFD4A49CC75BQ36379726-BEB401E1-1E70-494F-85AF-A893D3573D5CQ36414956-2507953E-DAB0-4C3B-B03C-7B75C968DF2AQ36843548-64D02EF5-263A-4FC8-B91C-EB8F2F6D94EFQ36930476-31E86069-5056-408F-AFF6-5D8CE4114ED0Q36998753-42E3BB90-A0DA-453A-B30C-A5A10ED93F57Q37030974-2C03FD99-2335-4AD2-AB28-BF4B7417C49FQ37281858-D75300A4-9CB5-4ED5-9E7D-B1D8D05EA3AAQ37379639-AB1439BA-C6FB-4DD4-A549-5F42C902024EQ37520695-2E95D6B2-9583-49BC-B850-2DB3CC4E5DA0Q37588091-3BA55BB7-0C9D-45A4-8862-5FC84375C453Q37616857-5B16ABD4-7919-41E6-8EAD-7248F8DABED2Q37642811-90E3096D-6FAD-449F-BE66-9FD274E7C62FQ37695098-E2366E86-FC47-4AC2-973A-DF54EDFE13B9Q37768108-12D2F403-5B88-4C86-B2D9-E0F42B909F64Q37865861-11BE77F2-0ACC-49DC-98FA-797D26D84ABFQ37907433-03A05483-80B0-42DB-818A-CE667830111AQ38103361-1EC6047F-BB19-4E29-9F21-08786FF6FB73Q38169443-EE68B797-83DB-406C-BA6A-A852E072EAECQ38237617-1B504F51-31F5-479E-B3E1-476E81F5F5EDQ38446380-3553785D-EEE2-44A8-91ED-BD4E8433502D
P50
description
researcher ORCID ID = 0000-0003-3715-2561
@en
name
Stuart J Forbes
@ast
Stuart J Forbes
@en
Stuart J Forbes
@nl
type
label
Stuart J Forbes
@ast
Stuart J Forbes
@en
Stuart J Forbes
@nl
prefLabel
Stuart J Forbes
@ast
Stuart J Forbes
@en
Stuart J Forbes
@nl
P21
P31
P496
0000-0003-3715-2561